Advaxis to permit its ADXS-HPV product applicant to FusionVax Advaxis.

Moore, Chairman and Chief Executive Officer of Advaxis.. Advaxis to permit its ADXS-HPV product applicant to FusionVax Advaxis, Inc., , a leader in developing another generation of immunotherapies for cancers and infectious diseases, announced that it offers entered into a Memorandum of Understanding with FusionVax, Inc. setting forth the primary terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product applicant, ADXS-HPV, to FusionVax for Asia.For even more on the #14Days challenge, check out these healthy lifestyle ideas and stress relief techniques. Also, hear what Dr. Drew said last week about addiction and stigma. And get inspired by Gabrielle Bernstein’s undertake recovery and miracles.

A new method of TBI therapy Innovative angles of attack in research that concentrate on how the human brain protects and repairs itself will help develop treatments for one of the most common, expensive, deadly and scientifically annoying medical conditions worldwide: traumatic brain injury.